journal article·2025-08

Strontium Hexacyanoferrate Nanomedicine Alleviates Ischemic Cardiomyopathy by Regulating Pyroptosis

Xi Li, Yu Yao, Xiangyi Ren, Liying Wang, Minfeng Huo, Jianlin Shi

Advanced Functional Materials· Volume 35· Issue 35
Publisher page

Abstract

Abstract Ischemic cardiomyopathy remains high mortality and morbidity worldwide due to dysfunctional cell metabolism and programmed death of cardiomyocytes. Restoration of the blocked blood flows is a major therapeutic approach against ischemic cardiomyopathy, which, unfortunately, may cause the burst of oxidative species damaging tissues (ischemic/reperfusion injury, IR). Cardiac antioxidation and revascularization are two major therapeutic aims in treating cardiac IR as well as myocardial infarction (MI). In the present work, strontium hexacyanoferrate (SrHF) nanoparticles are synthesized for alleviating both the cardiac pathologies of MI and IR concurrently. SrHF features high antioxidative catalytic activity, mimicking superoxide dismutase and catalase in eliminating reactive oxygen species for cardiac protection. In vivo, investigation confirms that SrHF has significantly alleviated myocardial functional deterioration and enhanced cardiomyocyte survival. Mechanistic studies demonstrate that SrHF can effectively inhibit cardiac programmed pyroptosis and pathological remodeling through antioxidation and enhance angiogenesis by bioactive strontium ions. The present work provides a promising therapeutic strategy in treating ischemic cardiac pathologies, providing a fundamental basis for clinical translation and application toward cardiovascular diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Pulmonary Hypertension Research and Treatments · Atomic and Subatomic Physics Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shanghai Tenth People's Hospital Shanghai Frontiers Science Center of Nanocatalytic Medicine The Institute for Biomedical Engineering and Nano Science School of Medicine Tongji University Shanghai 200072 P. R. China

Core Facilities of West China Hospital Sichuan University Chengdu 610041 P. R. China

State Key Laboratory of Cardiology and Medical Innovation Center Shanghai East Hospital School of Medicine Tongji University Shanghai 200120 P. R. China

Funding

National Natural Science Foundation of China · Shanghai Rising-Star Program · Natural Science Foundation of Shanghai Municipality

References (36)

Show source-provided references
1. 10.1038/s44161-024-00531-y10.1038/s44161-024-00531-y ↗
2. 10.1021/acsnano.0c0472710.1021/acsnano.0c04727 ↗
3. 10.1021/acsnano.2c1004310.1021/acsnano.2c10043 ↗
4. 10.1038/s41551-020-00637-110.1038/s41551-020-00637-1 ↗
5. 10.1038/nature1390910.1038/nature13909 ↗
6. 10.1002/adhm.20230016110.1002/adhm.202300161 ↗
7. 10.1002/smll.20200503810.1002/smll.202005038 ↗
8. 10.1038/s42255-019-0115-y10.1038/s42255-019-0115-y ↗
9. 10.1021/acsnano.2c1209110.1021/acsnano.2c12091 ↗
10. 10.1002/adtp.20210003610.1002/adtp.202100036 ↗
11. 10.1002/advs.20220499910.1002/advs.202204999 ↗
12. 10.1021/acsnano.4c0050910.1021/acsnano.4c00509 ↗
13. 10.1002/adfm.20211043210.1002/adfm.202110432 ↗
14. 10.1038/s41467-023-35828-210.1038/s41467-023-35828-2 ↗
15. 10.1002/anbr.20220014410.1002/anbr.202200144 ↗
16. 10.1038/s41467-023-43870-310.1038/s41467-023-43870-3 ↗
17. 10.1038/s41565-023-01346-x10.1038/s41565-023-01346-x ↗
18. 10.1002/adhm.20180034710.1002/adhm.201800347 ↗
19. 10.1038/s41467-019-12429-610.1038/s41467-019-12429-6 ↗
20. 10.1002/adma.20210672310.1002/adma.202106723 ↗
21. 10.1021/accountsmr.3c0026010.1021/accountsmr.3c00260 ↗
22. 10.1002/adma.20240565510.1002/adma.202405655 ↗
23. 10.1038/s41467-022-35503-y10.1038/s41467-022-35503-y ↗
24. 10.1016/j.mattod.2023.06.01510.1016/j.mattod.2023.06.015 ↗
25. 10.1016/j.cej.2024.15501910.1016/j.cej.2024.155019 ↗
26. 10.1016/j.nantod.2021.10122710.1016/j.nantod.2021.101227 ↗
27. 10.1001/jamacardio.2020.125110.1001/jamacardio.2020.1251 ↗
28. 10.1016/j.jacc.2024.04.05110.1016/j.jacc.2024.04.051 ↗
29. 10.1016/j.bioactmat.2020.08.03110.1016/j.bioactmat.2020.08.031 ↗
30. 10.1016/j.biomaterials.2023.12208810.1016/j.biomaterials.2023.122088 ↗
31. 10.1002/adfm.20230314710.1002/adfm.202303147 ↗
32. 10.1016/j.biomaterials.2022.12165410.1016/j.biomaterials.2022.121654 ↗
33. 10.1038/s41551-018-0227-910.1038/s41551-018-0227-9 ↗
34. 10.1021/acsnano.1c0942710.1021/acsnano.1c09427 ↗
35. 10.1016/j.bioactmat.2023.02.02710.1016/j.bioactmat.2023.02.027 ↗
36. 10.1126/sciadv.abe072610.1126/sciadv.abe0726 ↗